about
Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutionsChanges in how health plans provide behavioral health services.Medicaid's expenditures for newer pharmacotherapies for adults with disabilitiesPrescription drug use and expenditures among dually eligible beneficiariesEconomic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.Does managed care affect the diffusion of psychotropic medications?The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer.Availability of addiction medications in private health plans.Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.Collaborative care for depression in primary care: how psychiatry could "troubleshoot" current treatments and practicesWho are the new users of antipsychotic medications?Assessment of changes in utilization of health-care services after implementation of a prior authorization policy for atypical antipsychotic agents.Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States' Monitoring Mechanisms.Factors Associated with Geographic Variation in Psychiatric Prescription Drug Expenditures Among Medicaid Beneficiaries.Soldier, Elder, Prisoner, Ward: Psychotropics in the Era of Transinstitutionalization
P2860
Q33896766-F46C93B4-01C2-4B86-AAC8-4BF4B1AED418Q34315587-59AD518B-A0E1-446C-9A7E-D3FBAC0B6178Q34328776-35EF20A2-EC7A-4702-9B8F-E9C25EEDF2DCQ34328801-E2607069-259A-4524-9E12-3B9624A58A74Q34452717-303CFC22-E46B-49AD-ADA9-AC83D05CB543Q35112617-B2EAF6ED-94D2-4E36-95B7-0544A3D07946Q36115981-F9AA062D-24DB-4850-88B9-6CEB1A6A1BEEQ36594523-0A47A917-98AA-46E2-96EE-AEA155821435Q36726421-BDB0B2C0-07FD-4237-B55C-989D424FC5F7Q36895976-C8274C3A-D77B-48A8-8724-14A9C850AC55Q37337653-E08E2F09-3946-44DF-8003-DD34F8912CEFQ37730304-E63E33E3-2AB4-45D3-9686-5E7D3B2D4AA4Q38724641-ADCAC1B4-5C8C-406E-B4A2-62B81DD6B2EBQ38727636-58C8554D-FE61-4662-952F-787C5484CDE7Q44338227-AB9E8334-6B3B-4659-A511-960D19083B30Q58141622-3323792E-A36C-452A-A649-C8113D185CCF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mental health policy and psychotropic drugs
@ast
Mental health policy and psychotropic drugs
@en
type
label
Mental health policy and psychotropic drugs
@ast
Mental health policy and psychotropic drugs
@en
prefLabel
Mental health policy and psychotropic drugs
@ast
Mental health policy and psychotropic drugs
@en
P2860
P1433
P1476
Mental health policy and psychotropic drugs
@en
P2093
Howard H Goldman
Richard G Frank
P2860
P304
P356
10.1111/J.1468-0009.2005.00347.X
P407
P50
P577
2005-01-01T00:00:00Z